ANGANY's First Clinical Trial Concludes on Time and with Positive Results
ANGANY inc. announces the completion on schedule of its first clinical trial, assessing the safety and allergenicity of its therapeutic candidate against human allergy to cats. The study results were consistent throughout the 20 human adult cat...
Source: lelezard.com